首页> 外文期刊>Clinical Biochemistry >Therapeutic drug measurement of mycophenolic acid derivatives in transplant patients
【24h】

Therapeutic drug measurement of mycophenolic acid derivatives in transplant patients

机译:移植患者中霉酚酸衍生物的治疗药物测定

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: Mycophenolic acid, the active metabolite of the prodrug mycophenolate mofetil, is widely used as an immunosuppressive agent in transplant patients for the prophylaxis of acute rejection. Recent prospective trials suggested the need for therapeutic drug monitoring, which raises the necessity to acquire accurate methods to measure MPA and its metabolites. Objective: Present an overview of the reasons to monitor MPA and its metabolites as well as a review of the currently available methods for their determination. Methods: Articles published from January 1992 to December 2006 were reviewed. Results: Most of the cited references use either chromatographic or immunoassay techniques. Basic information about biological samples used for the analysis, sample preparation, stationary phase, mobile phase, detection mode and validation data are discussed. Current information suggests the feasibility to set up method(s) to monitor MPA and its metabolites in most centers.
机译:简介:霉酚酸是前药霉酚酸酯的活性代谢产物,被广泛用作移植患者的免疫抑制剂,用于预防急性排斥反应。最近的前瞻性试验表明需要对治疗药物进行监测,这增加了获得测量MPA及其代谢物的准确方法的必要性。目的:概述监测MPA及其代谢物的原因,并综述目前确定其的方法。方法:回顾1992年1月至2006年12月发表的文章。结果:大多数引用的参考文献使用色谱或免疫测定技术。讨论了用于分析的生物样品,样品制备,固定相,流动相,检测模式和验证数据的基本信息。当前信息表明在大多数中心建立监测MPA及其代谢物的方法的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号